Physician profile
Erika Crate
NPI 1033606488
$2,752.29
in general payments reported to CMS, 2019-2025
29 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $556 · 2022: $682 · 2023: $651 · 2024: $440 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,514.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $432.81 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $380.57 | 2023-2025 | Myfembree |
| Organon LLC | $262.71 | 2021-2025 | Nexplanon |
| Biogen, INC. | $225.38 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $183.87 | 2021-2025 | Slynd |
| Myovant Sciences INC. | $182.13 | 2021-2022 | |
| Evofem Biosciences, INC. | $179.26 | 2021-2024 | Phexxi |
| Exact Sciences Corporation | $115.22 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $109.46 | 2021-2025 | Myrbetriq, Veozah |
| Therapeuticsmd, INC. | $103.86 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.60 | 2021-2023 | |
| Pfizer INC. | $79.63 | 2021-2024 | |
| Daiichi Sankyo INC. | $50.26 | 2023 | Injectafer |
| Mayne Pharma Commercial LLC | $43.50 | 2021-2023 | |
| Agile Therapeutics, INC. | $40.38 | 2021-2023 | Twirla |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $30.07 | 2021-2022 | |
| Scynexis, INC. | $29.12 | 2022 | |
| Mission Pharmacal Company | $28.72 | 2021-2023 | Citranatal |
| Mycovia Pharmaceuticals, INC. | $23.47 | 2023 | Vivjoa |
| Ethicon US, LLC | $21.21 | 2021 | |
| Hologic Sales and Service, LLC | $20.73 | 2022 | |
| Smith+Nephew, INC. | $19.60 | 2021 | |
| Optumhealth Care Solutions, LLC | $18.79 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Kci USA, INC. | $18.43 | 2023 | Prevena |
| Merck Sharp & Dohme LLC | $14.91 | 2021 | |
| Aspira Women'S Health INC | $14.73 | 2024 | Ova1 |
| Lupin INC. | $13.63 | 2021 | |
| Shield Therapeutics INC | $13.53 | 2025 | |
| Davol INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Crate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.